Susceptibility of various Gram-negative bacteria to antibacterial agents: SMART in China 2019–2020

肉汤微量稀释 微生物学 生物 鲍曼不动杆菌 粘菌素 阿米卡星 阿兹屈南 抗菌剂 抗生素耐药性 铜绿假单胞菌 肺炎克雷伯菌 哌拉西林 抗生素 最小抑制浓度 细菌 亚胺培南 大肠杆菌 生物化学 遗传学 基因
作者
Ying Fu,Y. Chen,Yanfei Wang,Bingyan Yao,Pengcheng Li,Yunsong Yu
出处
期刊:BMC Microbiology [Springer Nature]
卷期号:24 (1)
标识
DOI:10.1186/s12866-024-03526-8
摘要

Abstract Background The Study for Monitoring Antimicrobial Resistance Trends (SMART) is an international surveillance program longitudinally monitoring aerobic and facultative Gram-negative bacteria (GNB) involvement in infections and their antimicrobial resistance profiles. Here the incidence and resistance patterns of Chinese GNB isolates from bloodstream infections (BSI), intraabdominal infections (IAI), respiratory tract infections (RTI) and urinary tract infections (UTI) to commonly used antibacterial agents has been updated. 4,975 GNB isolates collected from 22 hospitals across 7 regions of China from 2019 to 2020 were analyzed. Antimicrobial minimum inhibitory concentrations were assessed using broth microdilution, and susceptibility interpretations followed the breakpoints of European Committee on Antimicrobial Susceptibility Testing 2022 or Clinical and Laboratory Standards Institute. Results This study affirmed that Escherichia coli (Ec) was the most commonly identified GNB (32.1%) and then Klebsiella pneumoniae (Kp) (25.3%), Pseudomonas aeruginosa (Pa) (13.9%) and Acinetobacter baumannii (10.5%). The detection rates of carbapenem-resistant (CR) Enterobacterales varied across major infection sites, ranging from 10.3% in UTI to 18.9% in RTI. Specifically, the detection rates of CR-Kp and CR-Pa ranged from 16.2% in IAI to 35.8% in UTI and from 16.1% in UTI to 38.0% in RTI, respectively. Extended-spectrum β-lactamases (ESBL)-producing Ec and Kp bacteria exhibited over 91.7% susceptibility to carbapenems and at least 87.8% susceptibility to amikacin and colistin, but showed lower susceptibility to piperacillin/tazobactam (57.5–86.2%), levofloxacin (10.8–39.7%) and aztreonam (15.3–27.6%) across different infection sources. Amikacin showed higher efficacy against CR strains compared to other commonly used antibacterial drugs, with 80.0% susceptibility against CR-Ec and 82.3% susceptibility against CR-Pa, while only 36.3% susceptibility was observed against CR-Kp. Conclusions The study found varying incidences of CR isolates in Chinese hospitals. Treatment options remained limited due to resistance to multiple antibacterial agents. Carbapenems demonstrated effective antimicrobial in vitro activity against ESBL-producing Enterobacterales found in BSI, IAI, UTI and RTI, outperforming broad-spectrum cephalosporins and other β-lactamase inhibitors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
huofuman完成签到,获得积分10
刚刚
Damon发布了新的文献求助30
刚刚
劲秉应助bbb采纳,获得10
1秒前
水下月发布了新的文献求助10
2秒前
3秒前
BGI789发布了新的文献求助10
3秒前
小灰狼完成签到,获得积分10
4秒前
4秒前
余闻问发布了新的文献求助10
4秒前
5秒前
xindiya完成签到 ,获得积分10
5秒前
思源应助自治自律自洽采纳,获得10
5秒前
5秒前
科目三应助kmoyy采纳,获得10
5秒前
myw完成签到,获得积分10
6秒前
6秒前
7秒前
Catalina_S应助小晶豆采纳,获得10
8秒前
8秒前
壹拾叁叁发布了新的文献求助10
8秒前
科目三应助NINI采纳,获得10
9秒前
锅包肉发布了新的文献求助10
9秒前
行风发布了新的文献求助10
10秒前
慕青应助yuany采纳,获得10
11秒前
miaomiao发布了新的文献求助50
11秒前
11秒前
11秒前
义气的靖柏完成签到,获得积分10
12秒前
12秒前
12秒前
无花果应助潇洒馒头采纳,获得10
12秒前
Lorrie发布了新的文献求助10
12秒前
14秒前
14秒前
十一应助gaoyayaaa采纳,获得10
14秒前
14秒前
Lucas应助zsk12138采纳,获得10
14秒前
14秒前
15秒前
情怀应助fujun0095采纳,获得10
15秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Continuum thermodynamics and material modelling 2000
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 2000
Applications of Emerging Nanomaterials and Nanotechnology 1111
Les Mantodea de Guyane Insecta, Polyneoptera 1000
지식생태학: 생태학, 죽은 지식을 깨우다 700
Neuromuscular and Electrodiagnostic Medicine Board Review 700
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3469657
求助须知:如何正确求助?哪些是违规求助? 3062868
关于积分的说明 9080250
捐赠科研通 2753067
什么是DOI,文献DOI怎么找? 1510691
科研通“疑难数据库(出版商)”最低求助积分说明 697975
邀请新用户注册赠送积分活动 697938